↑

ClariPi, ‘3D Ultra-Low-Dose CT Imaging Technology’ Acquired US FDA Approval

2022-04-18

ClariPi, ‘3D Ultra-Low-Dose CT Imaging Technology’ Acquired US FDA Approval

ClariPi (CEO Kim Jong-hyo), a company specializing in AI (artificial intelligence) medical imaging solutions, announced on the 17th that “ClariPulmo, its product, obtained sales approval from the US Food and Drug Administration (FDA) on the 6th.”

ClariPi, ‘3D Ultra-Low-Dose CT Imaging Technology’ Acquired US FDA Approval

2022-04-18

ClariPi, ‘3D Ultra-Low-Dose CT Imaging Technology’ Acquired US FDA Approval

Headquarter (South Korea)

Email:

Phone:

Fax:

USA Office:

Email:

Phone:

ClariPi, ‘3D Ultra-Low-Dose CT Imaging Technology’ Acquired US FDA Approval

2022-04-18

ClariPi, ‘3D Ultra-Low-Dose CT Imaging Technology’ Acquired US FDA Approval

Headquarter (South Korea)

Email:

Phone:

Fax:

USA Office:

Email:

Phone:

New Partnerships at ClariPi

ClariPi will be at ROKO in Germany!